KGC Launches Premium Ingredient Brand "G1899," for the Global B2B Health Ingredient Market
MWN-AI** Summary
Korea Ginseng Corporation (KGC) has launched its new standardized ingredient brand, "G1899," marking its entry into the global business-to-business (B2B) health ingredient market. The brand’s name reflects KGC's historic legacy, originating in 1899, and aims to diversify its offerings beyond red ginseng to a broader portfolio of standardized natural ingredients. With a rising global demand for premium and functional health ingredients, KGC highlights its Korean red ginseng, recognized for its non-GMO, gluten-free properties and endorsed by the Korean Ministry of Food and Drug Safety for seven health benefits.
KGC introduced G1899 at SupplySide Global 2025 in Las Vegas, engaging with major food and supplement companies to present the scientific validity and quality control of its red ginseng products. The display included diverse formulations for functional foods and skincare, and emphasized KGC’s rigorous quality assurance practices, boasting over 430 safety tests on each ginseng batch.
In its commitment to quality, KGC utilizes contract cultivation with local farmers, ensuring adherence to high production standards. The company’s facilities have secured international certifications like HACCP and FSSC 22000, reinforcing its pharmaceutical-grade hygiene practices.
KGC's R&D Center supports innovation throughout the value chain and holds over 320 patents in ginseng science. The company’s standing is reflected in its No. 1 global market share in ginseng retail and traditional supplement sectors for over a decade, a feat complemented by its recognition with the Varro E. Tyler Award. KGC's strategy includes collaboration with global partners to enhance its competitive edge and deliver high-quality health ingredients worldwide, continuing its heritage of excellence.
MWN-AI** Analysis
The launch of Korea Ginseng Corporation's (KGC) premium ingredient brand "G1899" marks a strategic entry into the B2B health ingredient market that could influence both market dynamics and investor sentiment. With growing global demand for high-quality, natural health ingredients, KGC is well-positioned to capitalize on this trend due to its long-standing heritage, established scientific backing, and extensive quality control measures.
The brand emphasizes standardized red ginseng, recognized for its health benefits by the Korean Ministry of Food and Drug Safety. The scientific consensus, bolstered by over 1,200 published studies, lends credibility to KGC's claims and offers a competitive edge in attracting B2B partnerships with food and supplement companies globally. The strategic presentation of "G1899" at the SupplySide Global 2025 Trade Show underscores KGC’s commitment to showcasing its research and development capabilities, alongside robust quality assurance practices.
Investors should take note of KGC's rigorous quality control processes, including contract cultivation and extensive safety testing—over 430 per batch—enhanced by international certifications that assure global partners of the ingredient's safety and reliability. This level of standardization is likely to appeal to manufacturers seeking high-quality inputs for their products, potentially leading to lucrative contracts.
As the market for functional health ingredients continues to expand, KGC's recent innovations and variations of product formulations—from powders to gummies—will likely address diverse consumer preferences, enhancing its market reach. By leveraging a strong heritage and a commitment to science-backed benefits, KGC can drive B2B engagement and foster long-term partnerships.
In conclusion, KGC's G1899 initiative reflects an ambitious step towards reinforcing its global leadership in health ingredients, which could yield significant returns for stakeholders aligned with this forward-looking strategy. Keep an eye on market responses and potential partnerships stemming from this launch for investment opportunities.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
- KGC, a Global Health Leader, Expands into the B2B Ingredient Sector with Its Standardized Premium Brand "G1899"
- Showcases "G1899" at the World's Largest Ingredient Exhibition, SSG 2025, Highlighting the Excellence of Red Ginseng
- Demonstrates KGC's Quality Management Systems and Advanced R&D Capabilities for Sourcing High-Purity Natural Ingredients
- Plans to Standardize Red Ginseng and Other Natural Ingredients to Bring JungKwanJang's Science-backed benefits to Global Partners
SEOUL, South Korea, Nov. 6, 2025 /PRNewswire/ -- Global health and wellness company Korea Ginseng Corporation (KGC) has officially launched its standardized premium ingredient brand, "G1899," marking its entry into the global business-to-business (B2B) health ingredient market.
The name G1899 reflects KGC's deep-rooted heritage dating back to 1899—the year the JungKwanJang legacy began—and embodies the company's vision to expand from red ginseng to a diverse portfolio of standardized natural ingredients for global markets.
Amid rising global demand for premium, natural, and functional health ingredients, red ginseng continues to gain recognition as a natural, non-GMO, and gluten-free ingredient that aligns with modern wellness trends. Scientifically proven and naturally sourced, Korean red ginseng is recognized by the Korean Ministry of Food and Drug Safety for seven key health functions. Over 1,200 scientific papers worldwide have been published on the efficacy of ginseng and red ginseng.
Through G1899, KGC aims to extend its legacy beyond finished products, leveraging its globally recognized research capabilities and high-quality ingredient production to promote the value of JungKwanJang to partners and consumers worldwide.
G1899 Makes Global Debut at SSG 2025, the World's Largest Ingredient Trade Show
KGC unveiled G1899 at SupplySide Global 2025 (SSG 2025), held in Las Vegas from October 29–30, opening a new chapter in its global ingredient business. At the event, KGC introduced the scientific excellence of red ginseng ingredients to major global food and supplement companies, showcasing research data, rigorous quality control, and advanced formulation technologies.
The company highlighted its contract cultivation system, quality control, and R&D standardization processes for high-quality raw material development, as well as red ginseng's seven officially recognized functions. KGC also presented various formulations for functional food applications—liquid, powder, capsule, tablet, gummy, and even skincare—and shared details of its international certifications including FSSC 22000, cGMP, self-affirmed GRAS, and HALAL.
Particular attention was drawn to KGC's recent clinical findings, which attracted strong interest from global industry participants. KGC also offered on-site tasting sessions of health beverages made with red ginseng extracts and engaged visitors with creative K-content-inspired promotional activities.
"JungKwanJang Red Ginseng has established itself as a global leader in K-health supplements with its proven efficacy, heritage, and quality," said a KGC spokesperson. "By collaborating with global partners across ingredient and finished-product sectors, KGC will continue to strengthen its international competitiveness and deliver the excellence of our ingredients to consumers worldwide."
Commitment to Quality: Contract Cultivation and Pharmaceutical-Level Quality Control
KGC ensures the purity and consistency of its ingredients through contract cultivation with local farmers, beginning with soil management before planting. Every batch of ginseng undergoes more than 430 safety tests. Its production facilities have earned stringent international certifications including HACCP, and FSSC 22000, with the Wonju Plant being the first in Korea's health functional food industry to receive Smart HACCP certification.
Additionally, KGC's manufacturing standards are recognized globally with certifications from Australia's TGA, Japan's FMDA, and HALAL certification since 2014, attesting to its pharmaceutical-level hygiene and quality management systems.
KGC R&D Center: Setting Global Standards in Health Ingredient Research
KGC's R&D Center drives innovation across the entire value chain—from ingredient development and component analysis to product formulation—through international collaborations and accredited testing facilities. The company currently holds over 320 patents and has published more than 350 academic papers on ginseng science and natural product innovation.
In recognition of its excellence, KGC received the prestigious Varro E. Tyler Award from the American Botanical Council (ABC) at Natural Products Expo West 2025 in Anaheim. According to Euromonitor International (2014–2024), KGC has maintained the No. 1 market share globally for 11 consecutive years in both ginseng retail and herb/traditional supplement categories.
SOURCE KGC (Korea Ginseng Corp.)
FAQ**
How does the launch of KGC's G1899 brand align with KT&G Corporation GDR - 144A KTCIY's strategic goals in the health ingredient market?
What specific quality management systems does G1899 employ to ensure the premium standard of its red ginseng ingredients, particularly in relation to KT&G Corporation GDR - 144A KTCIY?
Can you elaborate on the anticipated impact of G1899's global debut at SSG 2025 on KT&G Corporation GDR - 144A KTCIY's global partnerships and market penetration?
How does KGC plan to leverage its research capabilities and patented innovations, particularly regarding KT&G Corporation GDR - 14KTCIY, to differentiate its G1899 brand in the competitive B2B health ingredient landscape?
**MWN-AI FAQ is based on asking OpenAI questions about KT&G Corporation GDR - 144A (OTC: KTCIY).
NASDAQ: KTCIY
KTCIY Trading
G/L:
$ Last:
0 Volume:
$ Open:
